SCM
BMRN icon

Suvretta Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Suvretta Capital Management’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,670
Closed -$276K – 95
2022
Q4 		$276K Buy
+2,670
New +$276K 0.01% 81